Results     04-May-21
Announcements
Alembic Pharmaceuticals consolidated net profit rises 11.46% in the March 2021 quarter
Sales rise 6.10% to Rs 1280.39 crore
Net profit of Alembic Pharmaceuticals rose 11.46% to Rs 250.70 crore in the quarter ended March 2021 as against Rs 224.93 crore during the previous quarter ended March 2020. Sales rose 6.10% to Rs 1280.39 crore in the quarter ended March 2021 as against Rs 1206.83 crore during the previous quarter ended March 2020.

For the full year,net profit rose 42.14% to Rs 1178.11 crore in the year ended March 2021 as against Rs 828.82 crore during the previous year ended March 2020. Sales rose 17.10% to Rs 5393.13 crore in the year ended March 2021 as against Rs 4605.75 crore during the previous year ended March 2020.

ParticularsQuarter EndedYear Ended
 Mar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.
Sales1280.391206.83 6 5393.134605.75 17
OPM %26.6927.14 -28.8826.55 -
PBDT343.08320.66 7 1551.551200.79 29
PBT291.86276.52 6 1368.081043.47 31
NP250.70224.93 11 1178.11828.82 42

Previous News
  Alembic Pharmaceuticals reports consolidated net profit of Rs 120.60 crore in the June 2023 quarter
 ( Results - Announcements 04-Aug-23   14:15 )
  Volumes soar at Alembic Pharmaceuticals Ltd counter
 ( Hot Pursuit - 30-Nov-23   14:30 )
  Alembic Pharma’s Gujarat facility gets 4 observations from USFDA
 ( Hot Pursuit - 09-Mar-24   09:04 )
  Volumes soar at Timken India Ltd counter
 ( Hot Pursuit - 30-Nov-23   11:00 )
  Alembic Pharma gets tentative USFDA nod for Brexpiprazole tablets
 ( Hot Pursuit - 09-Mar-23   09:18 )
  USFDA inspects Alembic Pharma's solid oral formulation facility at Jarod
 ( Corporate News - 19-Dec-22   12:51 )
  Alembic Pharmaceuticals reports consolidated net loss of Rs 65.88 crore in the June 2022 quarter
 ( Results - Announcements 04-Aug-22   17:27 )
  Alembic Pharma spurts on receiving USFDA nod for Ketorolac Tromethamine Injection
 ( Hot Pursuit - 03-Nov-22   13:12 )
  Alembic receives USFDA approval for Diclofenac Sodium Topical Solution
 ( Corporate News - 01-Dec-22   11:17 )
  USFDA issues EIR for Alembic's Panelav oncology injectable formulation unit
 ( Corporate News - 09-Dec-22   13:39 )
  Alembic Pharmaceuticals receives USFDA tentative approval for Bosutinib tablets
 ( Corporate News - 01-Jul-24   10:44 )
Other Stories
  Atlas Cycles (Haryana) reports standalone net loss of Rs 0.46 crore in the June 2024 quarter
  06-Jul-24   07:32
  Emerald Finance consolidated net profit rises 98.84% in the June 2024 quarter
  05-Jul-24   15:52
  Kronox Lab Sciences standalone net profit rises 140.98% in the March 2024 quarter
  29-Jun-24   07:31
  Performance Chemiserve standalone net profit rises 6062.22% in the March 2024 quarter
  27-Jun-24   07:24
  Sundew Properties standalone net profit rises 119.15% in the March 2024 quarter
  27-Jun-24   07:24
  IKF Home Finance standalone net profit rises 42.15% in the March 2024 quarter
  27-Jun-24   07:24
  Delhi Transco standalone net profit rises 1.08% in the March 2024 quarter
  27-Jun-24   07:24
  Profectus Capital Pvt standalone net profit rises 12.12% in the March 2024 quarter
  27-Jun-24   07:24
  Shrem Infra Invest Pvt consolidated net profit rises 290.12% in the March 2024 quarter
  27-Jun-24   07:24
  Bharat Ekansh reports consolidated net loss of Rs 0.01 crore in the March 2024 quarter
  27-Jun-24   07:24
Back Top